过去一年中添加的文章，按日期排序
Head-to-head ex vivo comparison of clinically used direct anticoagulant drugs
J Fadraersada, R Alva-Gallegos, P Skořepa… - Naunyn-Schmiedeberg's …, 2023 - Springer
215 天前 - … Prothrombin time (PT) and activated partial thromboplastin time (… effect was obtained
by argatroban followed by dabigatran and rivaroxaban while apixaban was the less active…
by argatroban followed by dabigatran and rivaroxaban while apixaban was the less active…
Efficacy and Safety of Activated Prothrombin Complex Concentrate for Reversal of the Anticoagulant Effect of Apixaban and Rivaroxaban in Patients with Major …
M Sheikh-Taha, HL Clark, RM Crawley - Clinical Drug Investigation, 2023 - Springer
269 天前 - … acknowledging these limitations, this study contributes new and important information
involving the use of aPCCs for the reversal of the effects of apixaban and rivaroxaban. …
involving the use of aPCCs for the reversal of the effects of apixaban and rivaroxaban. …